PI
EW icon

PEAK6 Investments’s Edwards Lifesciences EW Stock Holding History

PEAK6 Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.19M Buy
48,322
+40,325
+504% +$2.93M 0.01% 1202
2024
Q2 		$739K Buy
+7,997
New +$708K ﹤0.01% 2026
2023
Q4 		– Sell
-50,352
Closed -$3.5M – 4387
2023
Q3 		$3.49M Buy
50,352
+42,389
+532% +$3.41M 0.02% 953
2023
Q2 		$751K Buy
+7,963
New +$692K ﹤0.01% 1909
2023
Q1 		– Sell
-2,113
Closed -$166K – 4470
2022
Q4 		$158K Buy
+2,113
New +$163K ﹤0.01% 3424
2022
Q3 		– Sell
-7,963
Closed -$766K – 5114
2022
Q2 		$751K Sell
7,963
-34,602
-81% -$3.58M ﹤0.01% 1910
2022
Q1 		$5.01M Buy
42,565
+15,807
+59% +$1.77M 0.01% 1096
2021
Q4 		$3.47M Buy
+26,758
New +$3.12M 0.01% 1427
2021
Q2 		– Sell
-3,896
Closed -$367K – 5296
2021
Q1 		$326K Buy
+3,896
New +$329K ﹤0.01% 3561
2020
Q2 		– Sell
-3,114
Closed -$221K – 4487
2020
Q1 		$196K Buy
+3,114
New +$225K ﹤0.01% 2867
2019
Q3 		– Sell
-10,236
Closed -$719K – 3876
2019
Q2 		$630K Sell
10,236
-1,365
-12% -$82.5K ﹤0.01% 2108
2019
Q1 		$740K Sell
11,601
-3,393
-23% -$194K ﹤0.01% 2086
2018
Q4 		$766K Buy
+14,994
New +$759K ﹤0.01% 1989

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

PEAK6 Investments's EW Position: Q3 2024 in Review

PEAK6 Investments increased its Edwards Lifesciences (EW) stake by 504% in Q3 2024, buying an estimated $2.93M and bringing the position to 48,322 shares worth $3.19M. The position accounts for 0.01% of the portfolio, ranked #1202.

PEAK6 Investments first reported a position in EW in Q4 2018 and has held it in 13 quarters since. The position peaked at $5.01M in Q1 2022. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • PEAK6 Investments held 48,322 shares of Edwards Lifesciences worth $3.19M as of Q3 2024.
  • PEAK6 Investments bought 40,325 Edwards Lifesciences shares in Q3 2024, an estimated $2.93M.
  • Edwards Lifesciences made up 0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1202 holding.
  • PEAK6 Investments first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 13 quarters since.
  • PEAK6 Investments's Edwards Lifesciences position peaked at $5.01M in Q1 2022.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.